129 related articles for article (PubMed ID: 305464)
1. The induction of secondary cytolytic T lymphocytes by solubilized membrane proteins.
Mescher M; Sherman L; Lemonnier F; Burakoff S
J Exp Med; 1978 Mar; 147(3):946-51. PubMed ID: 305464
[TBL] [Abstract][Full Text] [Related]
2. The induction of virus-specific cytotoxic T lymphocytes with solubilized viral and membrane proteins.
Finberg R; Mescher M; Burakoff SJ
J Exp Med; 1978 Dec; 148(6):1620-7. PubMed ID: 214512
[TBL] [Abstract][Full Text] [Related]
3. Induction of allogeneic cytolytic T lymphocytes by partially purified membrane glycoproteins.
Sherman L; Burakoff SJ; Mescher MF
Cell Immunol; 1980 Apr; 51(1):141-50. PubMed ID: 6767550
[No Abstract] [Full Text] [Related]
4. Antigenic specificity of the cytolytic T lymphocyte (CTL) response to murine sarcoma virus-induced tumors. I. Preferential reactivity of in vitro generated secondary CTL with syngeneic tumor cells.
Plata F; Jongeneel V; Cerottini JC; Brunner KT
Eur J Immunol; 1976 Nov; 6(11):823-9. PubMed ID: 187429
[TBL] [Abstract][Full Text] [Related]
5. Specific lysis of murine cells expressing HLA molecules by allospecific human and murine H-2-restricted anti-HLA T killer lymphocytes.
Achour A; Begue B; Gomard E; Paul P; Sayagh B; Van Pel A; Levy JP
Eur J Immunol; 1986 Jun; 16(6):597-604. PubMed ID: 3522244
[TBL] [Abstract][Full Text] [Related]
6. Specific induction of syngeneic cytotoxic T lymphocytes by solubilized tumor antigen: fractionation of the specific R-MuLV-induced leukemia antigen.
Alaba O; Law LW
J Immunol; 1980 Jul; 125(1):414-9. PubMed ID: 6155403
[TBL] [Abstract][Full Text] [Related]
7. Studies on the cytolytic attack mechanism of the cytotoxic T lymphocyte (CTL): preparation of antisera against cellfree cytosolic extracts of a CTL clone capable of blocking the lethal hit stage of CTL cytolysis and analysis of the cytolytic structure.
Hiserodt JC
J Immunol; 1985 Jul; 135(1):53-62. PubMed ID: 3158707
[TBL] [Abstract][Full Text] [Related]
8. Cross-reacting antigens on L5178Y cells which serve as targets for cytotoxic T-lymphocyte lysis during establishment of the tumor dormant state.
Weinhold KJ; Wheelock EF
Cancer Res; 1982 Sep; 42(9):3607-16. PubMed ID: 6179603
[TBL] [Abstract][Full Text] [Related]
9. The induction of cytolytic T lymphocytes with purified plasma membranes.
Lemonnier F; Mescher TM; sherman L; Burakoff S
J Immunol; 1978 Apr; 120(4):1114-20. PubMed ID: 76660
[TBL] [Abstract][Full Text] [Related]
10. Loss of reactivity of a BALB/c myeoloma tumor with allogeneic and syngeneic cytotoxic T lymphocytes.
Russel JH; Hale AH; Inbar D; Eisen HN
Eur J Immunol; 1978 Sep; 8(9):640-5. PubMed ID: 309400
[TBL] [Abstract][Full Text] [Related]
11. Stimulation of different pathways of T-cell functions by syngeneic tumor cells and soluble membrane proteins.
Bertschmann M; Lüscher EF
Cell Immunol; 1983 May; 78(1):13-22. PubMed ID: 6602000
[TBL] [Abstract][Full Text] [Related]
12. Quantitative variations in the expression of H-2 antigens on murine leukemia virus-induced tumor cells can affect the H-2 restriction patterns of tumor-specific cytolytic T lymphocytes.
Plata F; Tilkin AF; Lévy JP; Lilly F
J Exp Med; 1981 Dec; 154(6):1795-810. PubMed ID: 6172533
[TBL] [Abstract][Full Text] [Related]
13. Interaction of cytotoxic T lymphocytes with target cells. I. Specific inhibition by detergent-solubilized, partially purified mouse histocompatibility antigens.
Whisnant CC; Singer KH; Amos DB
J Immunol; 1978 Dec; 121(6):2253-6. PubMed ID: 309895
[TBL] [Abstract][Full Text] [Related]
14. Cellular interactions in the generation of cytolytic T lymphocyte responses: role of Ia-positive splenic adherent cells in presentation in H-2 antigen.
Weinberger O; Herrmann SH; Mescher MF; Benacerraf B; Burakoff SJ
Proc Natl Acad Sci U S A; 1980 Oct; 77(10):6091-5. PubMed ID: 6969401
[TBL] [Abstract][Full Text] [Related]
15. T-cell-mediated cytotoxic immune responses to F9 teratocarcinoma cells: cytolytic effector T cells lyse H-2-negative F9 cells and syngeneic spermatogonia.
Wagner H; Starzinski-Powitz A; Röllinghoff M; Golstein P; Jakob H
J Exp Med; 1978 Jan; 147(1):251-64. PubMed ID: 415107
[TBL] [Abstract][Full Text] [Related]
16. Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. IV. Analysis of variant-specific antigens by selection of antigen-loss variants with cytolytic T cell clones.
Maryanski JL; Boon T
Eur J Immunol; 1982 May; 12(5):406-12. PubMed ID: 6178608
[TBL] [Abstract][Full Text] [Related]
17. Specificity studies on cytolytic T lymphocytes directed against murine leukemia virus-induced tumors. Analysis of monoclonal cytolytic T lymphocytes.
Plata F
J Exp Med; 1982 Apr; 155(4):1050-62. PubMed ID: 6174669
[TBL] [Abstract][Full Text] [Related]
18. Rauscher leukemia virus-induced tumor antigens: complete separation from gp70, p30 and H-2.
Alaba O; Rogers MJ; Law LW
Int J Cancer; 1979 Nov; 24(5):608-15. PubMed ID: 93583
[TBL] [Abstract][Full Text] [Related]
19. Tumors induced by murine sarcoma virus contain precursor cells capable of generating tumor-specific cytolytic T lymphocytes.
Chapdelaine JM; Plata F; Lilly F
J Exp Med; 1979 Jun; 149(6):1531-6. PubMed ID: 221614
[TBL] [Abstract][Full Text] [Related]
20. Phenotypic and functional properties of murine thymocytes. I. Precursors of cytolytic T lymphocytes and interleukin 2-producing cells are all contained within a subpopulation of "mature" thymocytes as analyzed by monoclonal antibodies and flow microfluorometry.
Ceredig R; Glasebrook AL; MacDonald HR
J Exp Med; 1982 Feb; 155(2):358-79. PubMed ID: 6120202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
